1. Asprosin in nonalcoholic fatty liver disease and hypothyroidism: a case-control study
- Author
-
Mona Abdel-Latif Aboul-Seoud, Mohamed Kamal Ghitany, Ola Atef Sharaki, Ahmed Alaa Abdul-Aziz, and Mohammed Said Sayed Shater
- Subjects
NAFLD ,hypothyroidism ,asprosin ,insulin resistance ,Medicine - Abstract
Purpose The present study aimed to determine the serum level of asprosin, a novel glucogenic and orexigenic hormone, in NAFLD and hypothyroidism patients.Methods This is a case–control study that included three groups of age and sex-matched subjects: hypothyroid patients with NAFLD (n = 26), hypothyroid patients without NAFLD (n = 25) and normal control subjects (n = 27). A detailed clinical history was obtained, and an examination was performed. Laboratory tests included fasting plasma glucose and insulin, lipid profile, TSH, free T4, AST, ALT, albumin, and asprosin. The homeostatic model assessment of insulin resistance (HOMA-IR) score was calculated. Abdominal ultrasonography was performed to calculate the hepatorenal index and define participants with NAFLD. The data were statistically analyzed.Results There was a statistically significant difference between the three groups regarding serum asprosin concentration (p
- Published
- 2024
- Full Text
- View/download PDF